1.560USD-3.70%Mkt Cap: 7.07M USDP/E: —Last update: 2026-05-22
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United Sta…
Industry Peers
Diagnostics & Research34.42BCHFP/E 37.9
21.61BUSDP/E 21.5
VIMIAN
Vimian Group AB (publ)15.51BSEKP/E 38.6
10.93BEURP/E 24.5
10.82BUSDP/E 46.6
8.65BEURP/E 21.9
7.72BUSD—
5.44BPLNP/E 21.7
loading…
Indicators:|
Key Statistics
Company
Market Cap7.07M USD
Enterprise Value3.83M USD
Revenue (TTM)6.16M USD
Gross Profit1.88M USD
Net Income (TTM)-14.91M USD
Revenue/Share3.580 USD
Last Price1.560 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees57
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.70
PEG—
EV/EBITDA-0.38
EV/Revenue0.62
P/S1.19
P/B1.00
EPS (TTM)-4.67
EPS (Forward)-0.60
52W Range
0.69306% of range15.00
52W High15.00 USD
52W Low0.6930 USD
Profitability
Gross Margin30.80%
Oper. Margin-196.95%
EBITDA Margin-163.38%
Profit Margin-244.10%
ROE-204.87%
ROA-136.03%
Growth
Revenue Growth-27.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.33M USD
CapEx (TTM)60.57K USD
FCF Margin-80.06%
FCF Yield-69.74%
Net Debt-5.29M USD
Net Debt/EBITDA0.53
Balance Sheet
Debt/Equity0.16
Current Ratio2.60
Quick Ratio2.41
Book Value/Sh1.619 USD
Cash/Share1.435 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateSep 19, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.53M
Float4.27M
Insiders3.26%
Institutions6.50%
Short Interest
Short Ratio0.0d
Short % Float11.69%
Short % Out.11.46%
Shares Short515.76K
Short (prev mo.)535.63K
Technical
SMA 502.739 (-43.0%)
SMA 2002.944 (-47.0%)
Beta-1.19
S&P 52W Chg28.31%
Avg Vol (30d)342.80K
Avg Vol (10d)210.07K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—